{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06132568",
            "orgStudyIdInfo": {
                "id": "S2496"
            },
            "organization": {
                "fullName": "Boston Scientific Corporation",
                "class": "INDUSTRY"
            },
            "briefTitle": "VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS)",
            "officialTitle": "VITALYST EFS: VITALYST Temporary Percutaneous Transvalvular Circulatory Support System Early Feasibility Study",
            "acronym": "VITALYST EFS",
            "therapeuticArea": [
                "Cardiovascular"
            ],
            "study": "vitalyst-early-feasibility-study-in-high-risk-pci-patients-vitalyst-efs"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-05-09",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-11-07",
            "studyFirstSubmitQcDate": "2023-11-09",
            "studyFirstPostDateStruct": {
                "date": "2023-11-15",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-18",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Boston Scientific Corporation",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "The VITALYST Early Feasibility study (EFS) is designed to evaluate the feasibility and safety of the VITALYST System in subjects undergoing elective high-risk percutaneous coronary intervention (HR-PCI).",
            "detailedDescription": "The VITALYST EFS is a prospective, open-label, single-arm, multicenter feasibility study of the VITALYST System.\n\nThe VITALYST System will be used to provide temporary circulatory support in patients undergoing non-emergent high risk percutaneous interventions (HR-PCI)."
        },
        "conditionsModule": {
            "conditions": [
                "High-risk Percutaneous Coronary Intervention",
                "Heart Disease, Coronary"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "DEVICE_FEASIBILITY",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "High Risk PCI Patients",
                    "type": "EXPERIMENTAL",
                    "description": "Patients undergoing non-emergent, high-risk percutaneous coronary interventions",
                    "interventionNames": [
                        "Device: VITALYST System"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "VITALYST System",
                    "description": "The VITALYST System is a temporary ventricular support device indicated for use during high-risk percutaneous coronary interventions (HR-PCI) performed electively in hemodynamically stable subjects with severe coronary artery disease.",
                    "armGroupLabels": [
                        "High Risk PCI Patients"
                    ],
                    "otherNames": [
                        "Percutaneous Mechanical Circulatory Support"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Clinical Success",
                    "description": "The primary endpoint consists of the composite endpoint of Clinical Success \\[measured through 72 hours or hospital discharge (whichever comes first)\\], which is defined as follows.\n\n* Technical Success: Successful delivery of the device to the correct anatomical position; and Successful operation and removal of the VITALYST circulatory support system\n* Absence of termination of revascularization procedure due to hemodynamic concern, or escalation to ECMO or other more intensive mechanical circulatory support device, or the use of vasopressors or inotropes\n* No conversion to open heart surgery\n* No mortality",
                    "timeFrame": "Measured through 72 hours or hospital discharge (whichever comes first) after the intervention/procedure"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Subject provides signed informed consent.\n* Subject is \u2265 18 years and \\< 90 years of age.\n* Subject is indicated for NON-emergent PCI of at least one de novo or restenotic lesion in a native coronary vessel or coronary artery bypass graft (CABG) and has left ventricular ejection fraction (LVEF) \u2264 50% with the following: Unprotected left main or Last remaining vessel or Three vessel disease (at least one \u2265 50% diameter stenosis based on center's visual assessment in all three major epicardial territories)\n* Heart team, which must include a cardiac surgeon, agrees that HR-PCI is appropriate.\n\nExclusion Criteria:\n\n* Subject has had STEMI within 72 hours with persistent elevation of cardiac enzymes.\n* Subject has had pre-procedure cardiac arrest requiring CPR within 24 hours of enrollment.\n* Subject has systolic blood pressure \\< 90 mmHg with evidence of end organ hypoperfusion (e.g., cool extremities or urine \\< 30 mL/hour).\n* Subject has had need for inotropes/vasopressors or mechanical circulatory support (including intra-aortic balloon pump) in the previous 24 hours to maintain a systolic blood pressure \u2265 90 mmHg.\n* Subject has left ventricular mural thrombus.\n* Subject has a prosthetic aortic valve.\n* Subject has pericarditis or constrictive heart disease (constrictive pericarditis or restrictive cardiomyopathy).\n* Subject has moderate or greater aortic valve stenosis or moderate or greater aortic valve insufficiency (by echocardiographic assessment, graded as \\> 2+).\n* Subject has abnormalities of the aorta that preclude safe delivery of the device, including severe calcification, tortuosity, aneurysm, or prior surgery.\n* Subject has PVD preventing passage of the device (e.g., calcification, small caliber) or tortuosity that would preclude safe placement of the introducer sheath as per the IFU.\n* Subject is not on dialysis and has creatinine \\> 4 mg/dL.\n* Subject has a history of liver dysfunction (Childs Class C) with elevation of liver enzymes and bilirubin \\> 3\u00d7 ULN or INR \u2265 2.\n* Subject has had a recent (within 30 days) stroke or TIA.\n* Subject has known hypersensitivity to intravenous contrast agents that cannot be adequately pre-medicated or has known hypersensitivity to heparin, aspirin, ADP receptor inhibitors or nitinol.\n* Subject has current or a history of heparin induced thrombocytopenia.\n* Subject has uncorrected abnormal coagulation or platelet count \u2264 75,000/mm\u00b3 or INR \u2265 2.0.\n* Subject has significant right heart failure based on any one of the following criteria: RVSWI \\< 0.30 mmHg\u00b7L/m\u00b2 or PVR \\> 3.6 Woods units or Pulmonary artery pulsatility index \\< 1.85\n* Subject requires non-elective mechanical ventilation.\n* Subject has an atrial or ventricular septal defect (including post-infarct VSD).\n* Subject has left ventricular rupture.\n* Subject has cardiac tamponade.\n* Subject has severe pulmonary disease (FEV1 \\< 1L).\n* Subject has sustained or non-sustained ventricular tachycardia.\n* Subject is breast feeding or is pregnant.\n* Subject has infection of the proposed procedural access site or active systemic infection.\n* Subject has any condition that requires premature discontinuation of recommended antiplatelet and/or anticoagulant therapy before 90 days following the index procedure.\n* Any use of a mechanical circulatory support device within 14 days prior to the index procedure.\n* Staged PCI is planned within 90 days following device removal.\n* Subject is participating in another investigational drug or device study that has not reached its primary endpoint.\n* Subject has other disease condition(s) resulting in the subject being unsuitable for participation in the clinical trial (e.g., advanced malignancy with limited expected survival)\n* Subject has other disease condition(s) which the Investigator has determined may cause non-compliance to the study requirements.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "89 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Alison Osattin",
                    "role": "CONTACT",
                    "phone": "800-876-9960",
                    "email": "alison.osattin@bsci.com"
                },
                {
                    "name": "Amy Maurer",
                    "role": "CONTACT",
                    "phone": "800-876-9960",
                    "email": "amy.maurer@bsci.com"
                }
            ],
            "locations": [
                {
                    "facility": "Brigham and Women's Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02115",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Taylor Munson",
                            "role": "CONTACT"
                        },
                        {
                            "role": "CONTACT",
                            "email": "tmunson@bwh.harvard.edu"
                        },
                        {
                            "name": "Kevin Croce, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Beth Israel Deaconess Medical Center",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jacob Luetje",
                            "role": "CONTACT",
                            "phone": "617-632-7484",
                            "email": "jluetje@bidmc.harvard.edu"
                        },
                        {
                            "name": "Robert Yeh, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Columbia University Medical Center/New York Presbyterian Hospital",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10032",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kate Dalton",
                            "role": "CONTACT",
                            "phone": "347-514-3366",
                            "email": "Keb2114@cumc.columbia.edu"
                        },
                        {
                            "name": "Ajay Kirtane, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Skane University Hospital",
                    "status": "RECRUITING",
                    "city": "Lund",
                    "zip": "222 42",
                    "country": "Sweden",
                    "contacts": [
                        {
                            "name": "Lotta Cinthio",
                            "role": "CONTACT",
                            "phone": "+46 (0)46-17 6005",
                            "email": "lotta.cinthio@skane.se"
                        },
                        {
                            "name": "Matthias Gotberg, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 55.70584,
                        "lon": 13.19321
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED",
            "description": "The data and study protocol for this clinical trial may be made available to other researchers in accordance with the Boston Scientific Data Sharing Policy (http://www.bostonscientific.com/en-US/data-sharing-requests.html)"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                },
                {
                    "id": "D000003327",
                    "term": "Coronary Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000017202",
                    "term": "Myocardial Ischemia"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "asFound": "Heart Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6546",
                    "name": "Coronary Artery Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M6549",
                    "name": "Coronary Disease",
                    "asFound": "Heart Disease, Coronary",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19506",
                    "name": "Myocardial Ischemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M10543",
                    "name": "Ischemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        }
    },
    "hasResults": false
}